Mexico
· Delayed Price · Currency is MXN Vertex Pharmaceuticals Statistics
Total Valuation
BMV:VRTX has a market cap or net worth of MXN 2.53 trillion. The enterprise value is 2.35 trillion.
| Market Cap | 2.53T |
| Enterprise Value | 2.35T |
Important Dates
The next estimated earnings date is Monday, May 5, 2025.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.00% |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 256.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.04 |
| PB Ratio | 7.41 |
| P/TBV Ratio | 8.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.26, with an EV/FCF ratio of -142.58.
| EV / Earnings | -210.39 |
| EV / Sales | 10.83 |
| EV / EBITDA | 24.26 |
| EV / EBIT | 25.99 |
| EV / FCF | -142.58 |
Financial Position
The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.69 |
| Quick Ratio | 2.17 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.36 |
| Debt / FCF | -2.21 |
| Interest Coverage | 150.08 |
Financial Efficiency
Return on equity (ROE) is -3.15% and return on invested capital (ROIC) is 15.71%.
| Return on Equity (ROE) | -3.15% |
| Return on Assets (ROA) | 12.68% |
| Return on Invested Capital (ROIC) | 15.71% |
| Return on Capital Employed (ROCE) | 24.21% |
| Revenue Per Employee | 37.64M |
| Profits Per Employee | -1.83M |
| Employee Count | 6,100 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 5.14 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.98% in the last 52 weeks. The beta is 0.51, so BMV:VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +38.98% |
| 50-Day Moving Average | 9,780.30 |
| 200-Day Moving Average | 9,315.69 |
| Relative Strength Index (RSI) | 33.12 |
| Average Volume (20 Days) | 151 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.91 |
Income Statement
In the last 12 months, BMV:VRTX had revenue of MXN 229.63 billion and -11.16 billion in losses. Loss per share was -43.34.
| Revenue | 229.63B |
| Gross Profit | 125.53B |
| Operating Income | 95.70B |
| Pretax Income | 5.18B |
| Net Income | -11.16B |
| EBITDA | 99.49B |
| EBIT | 95.70B |
| Loss Per Share | -43.34 |
Balance Sheet
The company has 127.44 billion in cash and 36.46 billion in debt, giving a net cash position of 197.42 billion.
| Cash & Cash Equivalents | 127.44B |
| Total Debt | 36.46B |
| Net Cash | 197.42B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 341.93B |
| Book Value Per Share | 1,330.79 |
| Working Capital | 125.69B |
Cash Flow
In the last 12 months, operating cash flow was -10.26 billion and capital expenditures -6.20 billion, giving a free cash flow of -16.47 billion.
| Operating Cash Flow | -10.26B |
| Capital Expenditures | -6.20B |
| Free Cash Flow | -16.47B |
| FCF Per Share | n/a |
Margins
Gross margin is 54.67%, with operating and profit margins of 41.67% and -4.86%.
| Gross Margin | 54.67% |
| Operating Margin | 41.67% |
| Pretax Margin | 2.25% |
| Profit Margin | -4.86% |
| EBITDA Margin | 43.33% |
| EBIT Margin | 41.67% |
| FCF Margin | n/a |
Dividends & Yields
BMV:VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.00% |
| Shareholder Yield | 1.00% |
| Earnings Yield | -0.44% |
| FCF Yield | -0.65% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BMV:VRTX has an Altman Z-Score of 13.47.
| Altman Z-Score | 13.47 |
| Piotroski F-Score | n/a |